[Assessment of routine surveillance of patients after primary treatment for cervical cancer in stage I. and II.: retrospective analysis].
OBJECTIVE
Evaluate the monitoring and diagnosis of recurrence after primary treatment for cervical cancer.


METHODS
Retrospective analysis.


METHODS
Department of Obstetrics and Gynecology Faculty Hospital and Constantine the Philosopher University Nitra.


METHODS
We retrospectively analyzed 199 patients who have undergone surgical treatment for cervical cancer between 2000 and 2008 at the Faculty Hospital Nitra and they received chemoradioterapy after evaluation of risk factors. Monitoring after primary treatment consisted of general physical examination, gynecological examination, vaginal and abdominal ultrasonography, chest X-ray and determining the level of SCCA. The examinations were performed by gynecologist and clinical oncologist. We compared the survival of patients with symptomatic and asymptomatic recurrences.


RESULTS
The recurrence after 6 months post primary therapy were identified in 17 cases. At the time recurrence diagnosis 3 patients were asymptomatic and 14 were symptomatic. Recurrences all 3 asymptomatic patients were detected during regular examinations. Asymptomatic and symptomatic patients had similar survival.


CONCLUSIONS
Regular monitoring of patients after primary treatment of cervical cancer in the rigid intervals and diagnosis of recurrence in the asymptomatic stage does not improve survival compared with symptomatic patients. It is necessary to re-evaluate the algorithm of follow-up not only in terms of survival but also in terms of economic consequences.
Gynekologicko-pôrodnícka klinika FN Nitra a Univerzita Konstantina Filozofa Nitra, Slovenská republika. lajtmanerik@gmail.com
E
E
Lajtman
M
M
Mlyncek
P
P
Uharcek
M
M
Matejka
M
M
Urban
D000328:Adult; D003131:Combined Modality Therapy; D003266:Continuity of Patient Care; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*